191 related articles for article (PubMed ID: 28158497)
21. Sarcopenia in Resected NSCLC: Effect on Postoperative Outcomes.
Nakamura R; Inage Y; Tobita R; Yoneyama S; Numata T; Ota K; Yanai H; Endo T; Inadome Y; Sakashita S; Satoh H; Yuzawa K; Terashima T
J Thorac Oncol; 2018 Jul; 13(7):895-903. PubMed ID: 29751134
[TBL] [Abstract][Full Text] [Related]
22. Respiratory strength and pectoralis muscle mass as measures of sarcopenia: Relation to outcomes in resected non-small cell lung cancer.
Sun C; Anraku M; Kawahara T; Karasaki T; Kitano K; Nagayama K; Sato M; Nakajima J
J Thorac Cardiovasc Surg; 2022 Mar; 163(3):779-787.e2. PubMed ID: 33317785
[TBL] [Abstract][Full Text] [Related]
23. Significance of preoperative evaluation of skeletal muscle index and immune-nutritional status for patients with early-stage non-small cell lung cancer.
Sato S; Sato M; Shinohara H
Gen Thorac Cardiovasc Surg; 2023 Jun; 71(6):354-362. PubMed ID: 36562876
[TBL] [Abstract][Full Text] [Related]
24. Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations?
Rossi S; Di Noia V; Tonetti L; Strippoli A; Basso M; Schinzari G; Cassano A; Leone A; Barone C; D'Argento E
Future Oncol; 2018 Apr; 14(10):919-926. PubMed ID: 29528255
[TBL] [Abstract][Full Text] [Related]
25. The value of physical performance measurements alongside assessment of sarcopenia in predicting receipt and completion of planned treatment in non-small cell lung cancer: an observational exploratory study.
Collins JT; Noble S; Chester J; Davies HE; Evans WD; Farewell D; Lester JF; Parry D; Pettit R; Byrne A
Support Care Cancer; 2018 Jan; 26(1):119-127. PubMed ID: 28721555
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of Sarcopenia in Lung Cancer: A Systematic Review and Meta-analysis.
Yang M; Shen Y; Tan L; Li W
Chest; 2019 Jul; 156(1):101-111. PubMed ID: 31128115
[TBL] [Abstract][Full Text] [Related]
27. The association between thoracic sarcopenia and survival is gender specific in early-stage lung cancer.
Wakefield CJ; Lund N; Coughlin J; Karush JM; Geissen N; Alex G; Liptay MJ; Borgia JA; Shah P; Seder CW
J Thorac Dis; 2022 Nov; 14(11):4256-4265. PubMed ID: 36524067
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive Assessment of the Clinical Risk Factors of Postoperative Adverse Events and Survival in Patients With Non-small-cell Lung Cancer.
Chang BS; Peng TC; Lue KH; Wu YF; Huang CH
In Vivo; 2023; 37(3):1358-1364. PubMed ID: 37103097
[TBL] [Abstract][Full Text] [Related]
29. Preoperative Geriatric Nutritional Risk Index: A predictive and prognostic factor in patients with pathological stage I non-small cell lung cancer.
Shoji F; Matsubara T; Kozuma Y; Haratake N; Akamine T; Takamori S; Katsura M; Toyokawa G; Okamoto T; Maehara Y
Surg Oncol; 2017 Dec; 26(4):483-488. PubMed ID: 29113668
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of cachexia score assessed by CT in male patients with small cell lung cancer.
Kim EY; Lee HY; Kim YS; Park I; Ahn HK; Cho EK; Jeong YM; Kim JH
Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28426181
[TBL] [Abstract][Full Text] [Related]
31. Sarcopenia is Associated with Perioperative Outcomes in Gastric Cancer Patients Undergoing Gastrectomy.
Shi B; Liu S; Chen J; Liu J; Luo Y; Long L; Lan Q; Zhang Y
Ann Nutr Metab; 2019; 75(4):213-222. PubMed ID: 31846973
[TBL] [Abstract][Full Text] [Related]
32. The Preoperative Controlling Nutritional Status Score Predicts Survival After Curative Surgery in Patients with Pathological Stage I Non-small Cell Lung Cancer.
Shoji F; Haratake N; Akamine T; Takamori S; Katsura M; Takada K; Toyokawa G; Okamoto T; Maehara Y
Anticancer Res; 2017 Feb; 37(2):741-747. PubMed ID: 28179325
[TBL] [Abstract][Full Text] [Related]
33. Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer.
Shoji F; Morodomi Y; Akamine T; Takamori S; Katsura M; Takada K; Suzuki Y; Fujishita T; Okamoto T; Maehara Y
Lung Cancer; 2016 Aug; 98():15-21. PubMed ID: 27393501
[TBL] [Abstract][Full Text] [Related]
34. Sarcopenia Adversely Impacts Postoperative Clinical Outcomes Following Gastrectomy in Patients with Gastric Cancer: A Prospective Study.
Wang SL; Zhuang CL; Huang DD; Pang WY; Lou N; Chen FF; Zhou CJ; Shen X; Yu Z
Ann Surg Oncol; 2016 Feb; 23(2):556-64. PubMed ID: 26668085
[TBL] [Abstract][Full Text] [Related]
35. Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study.
Shiroyama T; Nagatomo I; Koyama S; Hirata H; Nishida S; Miyake K; Fukushima K; Shirai Y; Mitsui Y; Takata S; Masuhiro K; Yaga M; Iwahori K; Takeda Y; Kida H; Kumanogoh A
Sci Rep; 2019 Feb; 9(1):2447. PubMed ID: 30792455
[TBL] [Abstract][Full Text] [Related]
36. Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder.
Miyake M; Morizawa Y; Hori S; Marugami N; Shimada K; Gotoh D; Tatsumi Y; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Tanaka N; Fujimoto K
BMC Cancer; 2017 Mar; 17(1):237. PubMed ID: 28359307
[TBL] [Abstract][Full Text] [Related]
37. Does sarcopenia have any impact on survival of patients with surgically treated non-small-cell lung cancer?
Deng HY; Zha P; Hou L; Huang KL
Interact Cardiovasc Thorac Surg; 2019 Jul; 29(1):144-147. PubMed ID: 30843065
[TBL] [Abstract][Full Text] [Related]
38. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
Duan X; Cui Y; Li H; Shi G; Wu B; Liu M; Chang D; Wang T; Kong Y
Indian J Cancer; 2015 Dec; 52 Suppl 3():E158-63. PubMed ID: 27453414
[TBL] [Abstract][Full Text] [Related]
39. Sarcopenia, as Assessed by Psoas Cross-Sectional Area, Is Predictive of Adverse Postoperative Outcomes in Patients Undergoing Colorectal Cancer Surgery.
Richards SJG; Senadeera SC; Frizelle FA
Dis Colon Rectum; 2020 Jun; 63(6):807-815. PubMed ID: 32149784
[TBL] [Abstract][Full Text] [Related]
40. Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A "hypothesis-generator" preliminary report.
Cortellini A; Verna L; Porzio G; Bozzetti F; Palumbo P; Masciocchi C; Cannita K; Parisi A; Brocco D; Tinari N; Ficorella C
Thorac Cancer; 2019 Feb; 10(2):347-351. PubMed ID: 30600905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
